Cargando…
CTNNB1 S45F Mutation Predicts Poor Efficacy of Meloxicam Treatment for Desmoid Tumors: A Pilot Study
We hypothesized that patterns of CTNNB1 (β-catenin) mutations would affect the outcome of conservative therapy in patients with desmoid tumors. This study aimed to determine the significance of CTNNB1 (β-catenin) mutations in predicting the treatment outcome in patients with desmoid tumors treated w...
Autores principales: | Hamada, Shunsuke, Futamura, Naohisa, Ikuta, Kunihiro, Urakawa, Hiroshi, Kozawa, Eiji, Ishiguro, Naoki, Nishida, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006838/ https://www.ncbi.nlm.nih.gov/pubmed/24788118 http://dx.doi.org/10.1371/journal.pone.0096391 |
Ejemplares similares
-
Characteristics of cultured desmoid cells with different CTNNB1 mutation status
por: Hamada, Shunsuke, et al.
Publicado: (2015) -
Less-invasive fascia-preserving surgery for abdominal wall desmoid
por: Nishida, Yoshihiro, et al.
Publicado: (2021) -
Expression of colony-stimulating factor 1 is associated with occurrence of osteochondral change in pigmented villonodular synovitis
por: Ota, Takehiro, et al.
Publicado: (2015) -
Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis
por: Sakai, Tomohisa, et al.
Publicado: (2017) -
Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial
por: Nishida, Yoshihiro, et al.
Publicado: (2020)